Table 3. Outcomes for 9 weeks for all participants by intervention and control group.
Outcomes for Specific Aim 1 (Reduction of Pain) | |||||||
Variable (range) | Intervention Baseline (N = 69) | Control Baseline (N = 69) |
Total (N = 138) |
||||
Mean (SD) | Mean (SD) | P-value | Mean (SD) | ||||
Average pain (0–10) | 6 (2.3) | 6 (2.0) | 0.61 | 6 (2.1) | |||
BPI Interference (0–10) | 6 (2.8) | 5 (2.5) | 0.64 | 6 (2.7) | |||
BPI Severity (0–10) | 6 (2.2) | 6 (2.2) | 0.94 | 6 (2.2) | |||
Outcome for Specific Aim 2 (Reduction of Depression) | |||||||
PHQ (0–27) | 11 (5.5) | 10 (5.7) | 0.15 | 10 (5.6) | |||
Outcomes for Specific Aim 3 (Increase of Pain Self-Efficacy and Reduced Use of Pain Medication) | |||||||
Pain Self-Efficacy (0–60) | 36 (15.7) | 34.8 (14.1) | 0.68 | 35 (14.8) | |||
n | % | n | % | P-value | n | % | |
Pain medication past 7 days | 53 | 77 | 54 | 78 | 0.84 | 107 | 78 |
Secondary Self Report Outcomes | |||||||
Mean (SD) | Mean (SD) | P-value | Mean (SD) | ||||
Perceived Stress Scale (0–16) | 7 (3.3) | 7 (3.7) | 0.85 | 7 (3.5) | |||
Patient Activation Measure (0–100) | 61 (13.6) | 62 (16.4) | 0.58 | 62 (15.0) | |||
SF-12 Physical Composite Score (0–100) | 36 (10.1) | 37 (10.4) | 0.68 | 36 (10.2) | |||
SF-12 Mental Composite Score (0–100) | 36 (9.9) | 39 (11.4) | 0.22 | 37 (10.7) | |||
Current Opioid Misuse Measure (0–64) | 9 (6.4) | 8 (6.0) | 0.22 | 9 (6.2) | |||
n | % | n | % | P-value | n | % | |
Emergency Department Use | 6 | 8 | 13 | 16 | 0.13 | 19 | 13 |